News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
217–252
Matches
289
Sources here
23
Companies here
8
Search results Stored financial headlines

Active search

289 matching headlines

Ticker or company: ELITMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

SEB Asset Management AB Acquires Shares of 104,667 Fidelity National Information Services, Inc. $FIS

SEB Asset Management AB has acquired 104,667 shares of Fidelity National Information Services, Inc. (FIS) valued at approximately $4.91 million in the first quarter. This comes as FIS reported better-than-expected Q1 earnings with $1.36 EPS and revenue up 30.1% year-over-year. Analyst sentiment is mixed, …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal Diseases

A recent H.C. Wainwright conference highlighted advancements in treating inherited retinal diseases, particularly Stargardt disease and retinitis pigmentosa. Belite Bio presented positive data for its drug tinlarebant, showing a significant reduction in macular lesion growth for Stargardt disease, while Nanoscope Therapeutics showcased MCO-010 as …

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Belite Bio (BLTE) Leerink’s Global Healthcare Conference 2025 Summary

This article summarizes Belite Bio's presentation at Leerink's Global Healthcare Conference 2025, focusing on their drug Tinlarebant for Stargardt disease and geographic atrophy. The summary details the disease background, drug mechanism, clinical trial designs (Phase II, DRAGON, DRAGON 2, and GA studies), and efficacy …

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National Financial sets Q2 2026 earnings release date

Fidelity National Financial (FNF) will announce its second-quarter 2026 earnings after the market closes on August 5, 2026. A conference call for investors and analysts is scheduled for August 6, 2026, at 11:00 a.m. Eastern Time. Investors can access the live webcast and replay …

FNF main company
Sharemaestro market context Price above Trend Line 52 weeks -12.3% FNF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National Financial Announces Second Quarter 2026 Earnings Release and Conference Call

Fidelity National Financial, Inc. (FNF) will release its second-quarter 2026 earnings after market close on Wednesday, August 5, 2026. A webcast and conference call to discuss these results will take place on Thursday, August 6, 2026, at 11:00 a.m. Eastern Time. Further details and …

FNF main company
Sharemaestro market context Price above Trend Line 52 weeks -12.3% FNF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National Information Services, Inc. (FIS) stock price, news, quote and history

This article provides a comprehensive overview of Fidelity National Information Services, Inc. (FIS), including its current stock price, market performance data, and key financial metrics. It details the company's business segments, recent news, performance against the S&P 500, earnings trends, and analyst ratings. The …

FIS main company F1NI34 main company FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Belite Bio stock price target maintained at $200 by H.C. Wainwright

H.C. Wainwright has reiterated a Buy rating and a $200 price target for Belite Bio (NASDAQ:BLTE), citing positive secondary endpoint data from its Phase 3 DRAGON trial for tinlarebant in Stargardt disease type 1. The stock has seen a 170% return over the past …

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ramp, FIS make AI moves

Fintech firm Ramp has launched a new spend management tool to help businesses monitor and control corporate expenses related to artificial intelligence usage. Meanwhile, processor Fidelity National Information Services (FIS) is collaborating with Anthropic on its Project Glasswing, an AI cybersecurity initiative, testing Anthropic's …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity D & D Bancorp, Inc. Third Quarter 2026 Dividend

Fidelity D & D Bancorp, Inc. announced its third-quarter dividend of $0.43 per share. The dividend will be paid on September 10, 2026, to shareholders of record as of August 14, 2026. The company, through its subsidiary The Fidelity Deposit and Discount Bank, serves …

FDBC main company
Sharemaestro market context Trend signal active 52 weeks +20.7% FDBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity D & D Bancorp second quarter 2026: $7.8M net income

Fidelity D & D Bancorp reported a net income of $7.8 million for the second quarter of 2026, marking an increase from $6.9 million in the prior year. The diluted EPS reached $1.33, while net interest income grew 16% to $20.8 million. Total assets …

FDBC main company
Sharemaestro market context Trend signal active 52 weeks +20.7% FDBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity D & D Bancorp (NASDAQ: FDBC) boosts Q2 earnings, assets

Fidelity D & D Bancorp reported strong Q2 2026 financial results with net income increasing by 13% to $7.8 million, or $1.33 per diluted share. This growth was driven by higher net interest income, increased loan balances, and improved deposit costs, leading to total …

FDBC main company
Sharemaestro market context Trend signal active 52 weeks +20.7% FDBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity D & D Bancorp, Inc. Reports Second Quarter 2026 Financial Results

Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) announced strong unaudited consolidated financial results for the second quarter and first half of 2026. The company reported a net income of $7.8 million or $1.33 per diluted share for Q2 2026, marking a 13% increase …

FDBC main company
Sharemaestro market context Trend signal active 52 weeks +20.7% FDBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Swiss National Bank Boosts Stock Position in Fidelity National Information Services, Inc. $FIS

Swiss National Bank increased its stake in Fidelity National Information Services (NYSE:FIS) by 6.1% in the first quarter, now owning 1,519,746 shares worth $71.29 million. Other institutional investors like Dodge & Cox, Capital Research Global Investors, Charles Schwab Investment Management Inc., Invesco Ltd., and …

FIS main company FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National Financial (FNF) Could Be 18% Below Fair Value On Its F And G Story

Fidelity National Financial (FNF) is deemed undervalued by 18.4% according to one narrative, suggesting a fair value of $62.20 compared to its current share price of $50.78. This bullish view is supported by the diversification of its F&G segment and a future earnings multiple …

FNF main company
Sharemaestro market context Price above Trend Line 52 weeks -12.3% FNF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Belite Bio, Inc (BLTE) Stock Analysis: A 37.73% Upside Potential in the Biotechnology Sector

Belite Bio, Inc (BLTE) is a clinical-stage biopharmaceutical company with a promising 37.73% upside potential, according to analyst ratings. The company is focused on developing therapies for Stargardt disease type 1 and geographic atrophy, with its lead product Tinlarebant (LBS-008) in phase 3 clinical …

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EpicQuest Education Announces New AI Tutorial Platform

EpicQuest Education Group International Limited (NASDAQ: EEIQ) has announced the beta testing of its new AI tutoring platform for students at Davis University and Davis Academy, with a full launch expected in September. The platform aims to provide individualized, adaptive learning, real-time feedback, and …

EEIQ main company
Sharemaestro market context Price below Trend Line 52 weeks -88.4% · Next-week setup negative 39.7% EEIQ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National’s Q2 2026 Earnings: What to Expect

Fidelity National Information Services (FIS) is set to release its Q2 2026 earnings on August 4, with analysts projecting an EPS of $1.47, an 8.1% increase from the previous year. Despite a significant stock decline over the past year, analysts have a "Moderate Buy" …

FIS main company F1NI34 main company FIS main company FNIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EpicQuest Education begins beta testing AI tutoring platform By Investing.com

EpicQuest Education Group International Limited (NASDAQ:EEIQ) is beta testing an AI tutoring platform for students at Davis University and Davis Academy in July, with a full launch planned for September. This platform aims to provide personalized learning support, real-time feedback, and 24/7 availability with …

EEIQ main company
Sharemaestro market context Price below Trend Line 52 weeks -88.4% · Next-week setup negative 39.7% EEIQ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EpicQuest Education Announces Beta Testing of AI Tutoring Platform for Davis University and Davis Academy Students

EpicQuest Education Group International Limited (EEIQ) has initiated beta testing for its new AI tutoring platform among students at Davis University and Davis Academy, with a full launch planned for September. This platform aims to provide personalized, adaptive learning with 24/7 availability and multilingual …

EEIQ main company
Sharemaestro market context Price below Trend Line 52 weeks -88.4% · Next-week setup negative 39.7% EEIQ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EpicQuest students will test an always-available AI tutor

EpicQuest Education (NASDAQ: EEIQ) is commencing a beta test of its new AI tutoring platform for students at Davis University and Davis Academy in July 2026. The platform aims to provide individualized, adaptive learning with 24/7 access and multilingual support, blending AI with traditional …

EEIQ main company
Sharemaestro market context Price below Trend Line 52 weeks -88.4% · Next-week setup negative 39.7% EEIQ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tinlarebant retinal marker stayed stable or fell ~2%; placebo rose 20%

Belite Bio reported additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant for Stargardt disease type 1. The data, presented at ASRS 2026 Annual Meeting, showed that quantitative autofluorescence remained stable to slightly decreased in tinlarebant-treated subjects, while it increased …

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does FIS’s Mythos 5 Cybersecurity Push Subtly Reframe Its AI-Led Risk and Compliance Narrative?

Earlier this month, Anthropic announced that Fidelity National Information Services joined Project Glasswing and began using the Mythos 5 AI model to help identify and address security vulnerabilities across its payment and core banking software infrastructure. This move highlights how FIS is applying advanced …

FIS main company F1NI34 main company FIS main company FNIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can Fidelity National Information Services (FIS) Stay Reasonable Despite Debt Concerns?

Fidelity National Information Services (FIS) stock is trading near US$42, down 67.7% over the past 5 years. While Simply Wall St's valuation checks suggest the stock is undervalued in 5 of 6 areas, indicating it might be priced more cheaply than its fundamentals suggest, …

FIS main company F1NI34 main company FIS main company FNIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National Information Services (FIS) Joins Project Glasswing As Its AI Narrative Meets Valuation

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Fidelity National Information Services (FIS) stock is back in focus after the company joined Anthropic's Project Glasswing, using the Mythos 5 AI model as …

FIS main company F1NI34 main company FIS main company FNIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

XS330970006 Bond Profile — Key Metrics

This article provides key metrics for the Fidelity National Information Services, Inc. XS330970006 bond. It details the issuer, issue and maturity dates, outstanding amount, face value, and coupon rate. The bond's issuer, Fidelity National Information Services, Inc., is described as a technology solutions provider …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Belite Bio completes FDA filing for tinlarebant in Stargardt disease type 1

Belite Bio has completed its New Drug Application (NDA) filing with the FDA for tinlarebant, aiming to treat Stargardt disease type 1. This news brief, generated by AI, is for informational purposes only and references original content published by Belite Bio via GlobeNewswire.

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FTA, FIS, PYPL, AIG: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the First Trust Large Cap Value AlphaDEX Fund (Symbol: FTA) where we have detected an approximate $243.5 million dollar outflow -- that's a 15.2% decrease …

FIS main company F1NI34 main company FIS main company FNIS main company
Sharemaestro market context Price below Trend Line 52 weeks -46.7% · Next-week setup negative 33.3% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dan Newhouse bought $ FIS on Jul. 10, 2026

Representative Dan Newhouse (R-WA04) purchased shares of FIDELITY NATIONAL INFORMATION SERVICES, INC. (FIS) on July 10, 2026. The transaction involved an amount between $1,001 and $15,000. This trade was disclosed on July 17, 2026, and since the trade date, FIS stock has seen a …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

Belite Bio announced additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant in Stargardt disease type 1 (STGD1), which demonstrated a marked divergence in quantitative autofluorescence (qAF) between treatment groups. Tinlarebant showed stable to slightly decreased qAF values, while placebo …

BLTE main company
Sharemaestro market context Price above Trend Line 52 weeks +152.8% · Next-week setup positive 55.4% BLTE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Heartland Advisors Inc. Acquires 61,248 Shares of Fidelity National Information Services, Inc. $FIS

Heartland Advisors Inc. significantly increased its stake in Fidelity National Information Services (NYSE:FIS) by 292.7% in the first quarter, purchasing an additional 61,248 shares. Several other institutional investors also adjusted their positions in FIS, which recently declared a quarterly dividend of $0.44 per share. …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AIA Group Ltd Boosts Holdings in Fidelity National Information Services, Inc. $FIS

AIA Group Ltd significantly increased its stake in Fidelity National Information Services (NYSE:FIS) by 59.2% in the first quarter, now owning 137,810 shares valued at $6.465 million. Other institutional investors also adjusted their positions in FIS. The article details analyst ratings, stock performance, and …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fidelity National Financial | 4: Statement of changes in beneficial ownership of securities-Director Dhanidina Halim

This document is a Statement of Changes in Beneficial Ownership of Securities (Form 4) for Director Dhanidina Halim of Fidelity National Financial. It details changes in the director's holdings of company securities, which is a standard regulatory disclosure.

FNF main company
Sharemaestro market context Price above Trend Line 52 weeks -12.3% FNF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FNF5259157 Bond Profile — Key Metrics

This article provides a detailed profile of the FNF5259157 bond issued by Fidelity National Financial, Inc. It outlines key metrics such as the coupon rate (3.2%), maturity date (September 17, 2051), and outstanding amount ($450 million USD). The bond profile also describes Fidelity National …

FNF main company
Sharemaestro market context Price above Trend Line 52 weeks -12.3% FNF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context